机译:肿瘤裂解物颗粒装载树突细胞疫苗:新型个性化癌症疫苗的临床前测试
Department of Surgery Madigan Army Medical Center Ft. Lewis WA 98431 ?USA;
Department of Surgical Oncology University of Texas MD Anderson Cancer Center Houston TX 77030;
Department of Surgical Oncology University of Texas MD Anderson Cancer Center Houston TX 77030;
Department of Surgery San Antonio Military Medical Center Ft. Sam Houston TX 78234 USA;
Department of Surgery San Antonio Military Medical Center Ft. Sam Houston TX 78234 USA;
Department of Surgery San Antonio Military Medical Center Ft. Sam Houston TX 78234 USA;
Department of Surgery San Antonio Military Medical Center Ft. Sam Houston TX 78234 USA;
Department of Surgery San Antonio Military Medical Center Ft. Sam Houston TX 78234 USA;
Orbis Health Solutions Greenville SC 29607 USA;
Perseus PCI George Town Grand Cayman ?Cayman Islands;
Department of Biological Sciences ?Clemson University Clemson SC 29631 USA;
Orbis Health Solutions Greenville SC 29607 USA;
Orbis Health Solutions Greenville SC 29607 USA;
dendritic cell; immunotherapy; solid tumor; vaccine;
机译:肿瘤裂解物颗粒装载树突细胞疫苗:新型个性化癌症疫苗的临床前测试
机译:固体肿瘤患者的自体肿瘤裂解物,颗粒肿瘤裂解物,颗粒式的树突细胞(TLPLDC)疫苗的初始I / IIa试验结果
机译:300?最终分析肿瘤裂解物的前瞻性,随机,双盲,安慰剂对照相IIB试验,III / IV黑色素瘤中颗粒裂解,树突细胞疫苗:36个月分析
机译:分子提示向树突状细胞的抗肿瘤疫苗。
机译:肿瘤裂解物与肽负载树突细胞疫苗接种策略的结合,用于积极的癌症免疫治疗。
机译:多机构前瞻性随机双盲安慰剂控制的肿瘤裂解物粒子树突细胞(TLPLDC)疫苗的疫苗以防止高危黑色素瘤患者的复发:亚组分析
机译:ASO作者反射:肿瘤裂解物,颗粒式,直阶段黑色素瘤的树突细胞疫苗:对个性化癌症疫苗接种的思考
机译:年度临床试验2007年1月1日至12月31日新型树突状细胞前列腺癌疫苗的临床前评估;